Regulatory approvals for Crispr Therapeutics' CASGEVY program are increasing, expanding the potential market for the treatment. Government support, including public funds, is likely to be available ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative ...
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...
Healthcare stocks as a group have not performed on par with broader equities this year. However, that doesn't mean investors ...
SAN DIEGO--(BUSINESS WIRE)--On January 9 th 2023, CRISPR QC has announced that they have closed their Seed Round at $1.6M and appoints George Bonaros to Board of Directors to fuel commercial growth of ...
Both stocks are risky, but one is far less so. This juicy upside potential comes at a cost. Investors seeking stocks with ...
Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Scientists at Israel’s Agricultural Research Organization (ARO), Volcani Center in Rishon Lezion, have used CRISPR-Cas9 genome editing tools to create a new strain of tilapia that does not develop ...
Gene-edited fruits in the produce aisle may be coming soon In A Nutshell Scientists used CRISPR gene editing to create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback